<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1S. Hacein-Bey-Abina, Marina Cavazzana, Philippe Leboulch et al.|Science|2003Cited by 3.5k
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Jacques J. M. van Dongen, Elizabeth Macintyre, Anton W. Langerak et al.|Leukemia|2003Cited by 3k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Salima Hacein‐Bey‐Abina, Marina Cavazzana, Alexandrine Garrigue et al.|Journal of Clinical Investigation|2008Cited by 1.8k
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaÉric Jourdan, Hervé Dombret, Nicolas Boissel et al.|Blood|2013Cited by 357
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok et al.|Blood|2009Cited by 270